Conference Coverage

Glioblastomas are fast, aggressive, and resistant to many standard therapies. Dr. Lauren Schaff, a neuro-oncologist at Memorial Sloan Kettering Cancer Center, expla…

The FDA approval of vorasidenib marks a new era for mutant isocitrate dehydrogenase (mIDH) gliomas. Approved in 2024 for grade 2 tumors after surgery, it doubled pr…

Defined by the production of 2-hydroxyglutarate, mutant isocitrate dehydrogenase (mIDH) gliomas are diffuse, slow-growing tumors. Managing these tumors requires per…

The impacts of climate change present a growing threat to brain health. Rising heat, air pollution, and oxidative stress appear to worsen conditions like strok…

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) can present in multiple ways, making diagnosis complex. Dr. Sami Khella joins the program to outline …

Melanoma treatment has undergone a rapid evolution. Immunotherapy has doubled survival rates, and timing the use of these drugs around surgery has shown to be ev…

While multiple kinds of animal models are commonly used to study multiple sclerosis (MS), they are not always ideal for getting the full picture of the dis…

Phototherapy, biologics, and JAK inhibitors can all play a role in atopic dermatitis treatment, but it’s essential to consider patient-specific factors bef…

For patients with Crohn’s disease who require surgery, a variety of risk factors are involved in postoperative recovery and disease control. Learn how prehabilitat…

While inflammatory bowel disease (IBD) does not typically cause significant problems in pregnancy, it’s still essential to discuss potential impacts with pa…

With the constant ups and downs of inflammatory bowel disease (IBD), consistent mon…

For many patients with Crohn’s disease, surgery is necessary due to complications like strictures and fistulas. Dr. Elisa Boden explores risk factors and potential…

Here to share a glimpse into where the dermatology field might be headed based on updates from the Maui Derm 2025 conference is Dr. Raj Chovatiya. Dr. Chovatiya…

How should we approach caring for undifferentiated eczema patients who didn’t have eczema as a child, who doesn’t have atopic co-morbidities, and isn’t flexural…

Here to share his insights on the key themes and topics covered at the Maui Derm 2025 conference is Dr. Raj Chovatiya. Dr. Chovatiya is a Clinical Associate Pro…

In light of the Maui Derm 2025 conference, Dr. Raj Chovatiya is here to discuss the most significant updates in the dermatology field that helped define 2024. D…

ALS can take up to a year to diagnose, but researchers are hard at work trying to find ways to minimize diagnostic delays and errors. One such solution is the R…

One of the major changes that's occurred very recently in the field of neurodegenerative disease and Alzheimer's disease, specifically, are the recently appro…

Prostate-specific membrane antigen (PSMA) PET scans are a method by which clinicians can see if a patient who is suffer…

When looking at patients who suffer from prostate cancer who are receiving PSMA therapy, we can see on our images that the medication not only goes t…